drugset / Trial / NCT00721812

A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686

NCT00721812 ↗

Phase 1 Completed 87 enrolled GlaxoSmithKline
RandomizedCrossoverSingle-blindTreatment

Summary

A First-Time-in-Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686 After Single and Repeated Oral Dosing in Healthy Volunteers

Timeline

Start
2008-09-25
Primary completion
2009-05-27
Completion
2009-05-27

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK1399686 Unknown — Oral